Skip to main content

Table 7 Multivariate analyses of risk factors for HBdec

From: Role of the initial degree of anaemia and treatment model in the prognosis of gastric cancer patients treated by chemotherapy: a retrospective analysis

Variable

p value

HR

95% CI

Chemotherapy included platinum

0.019

0.661

0.468–0.934

Metastatic sites ≥3

0.371

0.895

0.702–1.141

Bone metastases

0.055

0.633

0.396–1.010

Chemotherapy included paclitaxel

0.061

1.226

0.991–1.517

Number of chemotherapy cycles

< 0.001

0.938

0.911–0.966

Liver metastases

0.060

1.227

0.991–1.520

Treatment response

0.111

0.833

0.665–1.043